address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,hasPrePostMarketData,firstTradeDateMilliseconds,shortName,longName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,marketState,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,trailingPegRatio
Kalpataru Inspire,3rd Floor Off. Western Expressway Highway Santacruz (East),Mumbai,400055,India,91 22 6640 2323,91 22 6640 2051,https://www.lupin.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.","[{'maxAge': 1, 'name': 'Ms. Vinita D. Gupta', 'age': 56, 'title': 'CEO & Executive Director', 'yearBorn': 1968, 'fiscalYear': 2024, 'totalPay': 235590000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ramesh  Swaminathan', 'age': 58, 'title': 'Executive Director, Global CFO, CRO & Head of API, Sustainability and IT', 'yearBorn': 1966, 'fiscalYear': 2024, 'totalPay': 73610000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nilesh Deshbandhu Gupta', 'age': 50, 'title': 'MD & Executive Director', 'yearBorn': 1974, 'fiscalYear': 2024, 'totalPay': 95780000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christoph  Funke', 'title': 'Chief Technical Operations Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sreeji  Gopinathan', 'title': 'Chief Information Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Shahin  Fesharaki', 'title': 'President -Global Chief Scientific Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ravi  Agrawal', 'title': 'Sr. Vice President of Investor Relations and M&A', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sofia  Mumtaz', 'title': 'President of Legal and Compliance of Australia, Japan & Canada Business', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Amit Kumar Gupta', 'title': 'Company Secretary & Compliance Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Rajalakshmi  Azariah', 'title': 'Vice President & Global Head of Corporate Communications', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",10,2,5,1,3,1748736000,1735603200,[],86400,2,1931.8,1928.0,1920.6,1954.7,1931.8,1928.0,1920.6,1954.7,8.0,0.41,1721088000,0.1116,0.53,0.307,27.180132,23.82583,753303,753303,1139581,924011,924011,0.0,0.0,0,0,889965182976,1543.0,2402.9,3.9191875,2010.388,2085.308,12.0,0.006211823,INR,False,894856790016,0.14451,242337653,456695008,0.47076,0.36898997,456860992,377.02,5.166835,1743379200,1774915200,1743379200,1.149,32816199680,71.67,81.76,5:1,1282867200,3.941,16.28,0.23754,0.094471335,8.0,1721088000,EQUITY,1948.0,2626.0,1889.0,2259.9722,2270.0,2.25,buy,36,42014400512,92.076,54966898688,54477701120,1.086,1.875,227078995968,31.5,497.874,0.10167,0.20881,158656495616,6745200128,29999400960,1.147,0.142,0.69868,0.24205999,0.17865999,INR,LUPIN.NS,en-US,US,Equity,Delayed Quote,True,HIGH,False,1000093500000,LUPIN LIMITED,Lupin Limited,[],1750413600,NSI,finmb_9643983,Asia/Kolkata,IST,19800000,in_market,False,0.8385936,1948.0,POSTPOST,16.199951,1920.6 - 1954.7,NSE,1139581,405.0,0.2624757,1543.0 - 2402.9,-454.8999,-0.18931288,23.754002,1747220340,1754305140,1754654400,1739365200,1739365200,True,71.67,81.76,88.29433,22.062572,-62.38794,-0.031032786,-137.3081,-0.065845475,15,15,2.3 - Buy,False,
